163 related articles for article (PubMed ID: 31935510)
1. The suppression effects of feeding and mechanisms in CRF system of animals.
Qi J; Zhang X; Li Y; Xu S; Wang M; Chen H; Tang N; Wang S; Wang B; Chen D; Zhou B; Li Z
Gene; 2020 Apr; 733():144363. PubMed ID: 31935510
[TBL] [Abstract][Full Text] [Related]
2. Corticotropin-releasing factor-binding protein (CRF-BP) inhibits CRF- and urotensin-I-mediated activation of CRF receptor-1 and -2 in common carp.
Manuel R; Metz JR; Flik G; Vale WW; Huising MO
Gen Comp Endocrinol; 2014 Jun; 202():69-75. PubMed ID: 24769042
[TBL] [Abstract][Full Text] [Related]
3. Urocortin is the principal ligand for the corticotrophin-releasing factor binding protein in the ovine brain with no evidence for a sauvagine-like peptide.
Baigent SM; Lowry PJ
J Mol Endocrinol; 2000 Feb; 24(1):53-63. PubMed ID: 10656997
[TBL] [Abstract][Full Text] [Related]
4. Widespread tissue distribution and diverse functions of corticotropin-releasing factor and related peptides.
Boorse GC; Denver RJ
Gen Comp Endocrinol; 2006 Mar; 146(1):9-18. PubMed ID: 16413023
[TBL] [Abstract][Full Text] [Related]
5. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor.
Vaughan J; Donaldson C; Bittencourt J; Perrin MH; Lewis K; Sutton S; Chan R; Turnbull AV; Lovejoy D; Rivier C
Nature; 1995 Nov; 378(6554):287-92. PubMed ID: 7477349
[TBL] [Abstract][Full Text] [Related]
6. Desensitization of human CRF2(a) receptor signaling governed by agonist potency and βarrestin2 recruitment.
Hauger RL; Olivares-Reyes JA; Braun S; Hernandez-Aranda J; Hudson CC; Gutknecht E; Dautzenberg FM; Oakley RH
Regul Pept; 2013 Sep; 186():62-76. PubMed ID: 23820308
[TBL] [Abstract][Full Text] [Related]
7. Urocortin interaction with corticotropin-releasing factor (CRF) binding protein (CRF-BP): a novel mechanism for elevating "free' CRF levels in human brain.
Behan DP; Khongsaly O; Ling N; De Souza EB
Brain Res; 1996 Jul; 725(2):263-7. PubMed ID: 8836534
[TBL] [Abstract][Full Text] [Related]
8. Urocortins of the South African clawed frog, Xenopus laevis: conservation of structure and function in tetrapod evolution.
Boorse GC; Crespi EJ; Dautzenberg FM; Denver RJ
Endocrinology; 2005 Nov; 146(11):4851-60. PubMed ID: 16037378
[TBL] [Abstract][Full Text] [Related]
9. The effects of CRF and the urocortins on the hippocampal acetylcholine release in rats.
Pintér D; Balangó B; Simon B; Palotai M; Csabafi K; Dobó É; Ibos KE; Bagosi Z
Neuropeptides; 2021 Aug; 88():102147. PubMed ID: 33932861
[TBL] [Abstract][Full Text] [Related]
10. Appetite-suppressing effects of urocortin, a CRF-related neuropeptide.
Spina M; Merlo-Pich E; Chan RK; Basso AM; Rivier J; Vale W; Koob GF
Science; 1996 Sep; 273(5281):1561-4. PubMed ID: 8703220
[TBL] [Abstract][Full Text] [Related]
11. Changes in corticotropin releasing factor system transcript levels in relation to feeding condition in Acipenser dabryanus.
Qi J; Xu S; Wang M; Chen H; Tang N; Wang B; Li Y; Zhang X; Chen D; Zhou B; Zhao L; Wang Y; Li Z
Peptides; 2020 Jun; 128():170309. PubMed ID: 32259550
[TBL] [Abstract][Full Text] [Related]
12. Corticotropin-releasing hormone skin signaling is receptor-mediated and is predominant in the sebaceous glands.
Krause K; Schnitger A; Fimmel S; Glass E; Zouboulis CC
Horm Metab Res; 2007 Feb; 39(2):166-70. PubMed ID: 17326013
[TBL] [Abstract][Full Text] [Related]
13. Corticotropin-releasing factor, sauvagine, and urotensin I: effects on blood flow.
Lenz HJ; Fisher LA; Vale WW; Brown MR
Am J Physiol; 1985 Jul; 249(1 Pt 2):R85-90. PubMed ID: 3874558
[TBL] [Abstract][Full Text] [Related]
14. Evolution and physiology of the corticotropin-releasing factor (CRF) family of neuropeptides in vertebrates.
Lovejoy DA; Balment RJ
Gen Comp Endocrinol; 1999 Jul; 115(1):1-22. PubMed ID: 10375459
[TBL] [Abstract][Full Text] [Related]
15. Urotensin I-CRF-Urocortins: a mermaid's tail.
Pittman QJ; Hollenberg MD
Gen Comp Endocrinol; 2009 Oct; 164(1):7-14. PubMed ID: 19409389
[TBL] [Abstract][Full Text] [Related]
16. Urocortins: CRF's siblings and their potential role in anxiety, depression and alcohol drinking behavior.
Ryabinin AE; Tsoory MM; Kozicz T; Thiele TE; Neufeld-Cohen A; Chen A; Lowery-Gionta EG; Giardino WJ; Kaur S
Alcohol; 2012 Jun; 46(4):349-57. PubMed ID: 22444954
[TBL] [Abstract][Full Text] [Related]
17. Regulation of corticotropin-releasing factor and urocortin 2/3 mRNA by leptin in hypothalamic N39 cells.
Yamagata S; Kageyama K; Akimoto K; Watanuki Y; Suda T; Daimon M
Peptides; 2013 Dec; 50():1-7. PubMed ID: 24083959
[TBL] [Abstract][Full Text] [Related]
18. Contribution of Urocortin to the Development of Excessive Drinking.
Ryabinin AE; Giardino WJ
Int Rev Neurobiol; 2017; 136():275-291. PubMed ID: 29056154
[TBL] [Abstract][Full Text] [Related]
19. Urocortin 1, urocortin 3/stresscopin, and corticotropin-releasing factor receptors in human adrenal and its disorders.
Fukuda T; Takahashi K; Suzuki T; Saruta M; Watanabe M; Nakata T; Sasano H
J Clin Endocrinol Metab; 2005 Aug; 90(8):4671-8. PubMed ID: 15914529
[TBL] [Abstract][Full Text] [Related]
20. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor.
Lewis K; Li C; Perrin MH; Blount A; Kunitake K; Donaldson C; Vaughan J; Reyes TM; Gulyas J; Fischer W; Bilezikjian L; Rivier J; Sawchenko PE; Vale WW
Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7570-5. PubMed ID: 11416224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]